Syncom Formulations (India) Limited (SYNCOMF) — Capital Reinvestment Ratio
Syncom Formulations (India) Limited (SYNCOMF) has a Capital Reinvestment Ratio of 0.42x as of March 2025, meaning it reinvests 0% of its operating cash flow (Rs234.36 Million) in capital expenditures (Rs99.59 Million). See debt-free asset ratio of Syncom Formulations (India) Limited to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Syncom Formulations (India) Limited Capital Reinvestment Ratio (2006–2025)
This chart tracks Syncom Formulations (India) Limited's Capital Reinvestment Ratio across 13 annual periods. Check Syncom Formulations (India) Limited cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Syncom Formulations (India) Limited (2006–2025)
Year-by-year Capital Reinvestment Ratio for Syncom Formulations (India) Limited from 2006 to 2025. For live market cap and broader valuation context, see SYNCOMF stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.42x | Rs234.36 Million | Rs99.59 Million | ▼ -78.3% |
| 2023 | 1.96x | Rs105.29 Million | Rs206.35 Million | ▲ +182.9% |
| 2022 | 0.69x | Rs163.29 Million | Rs113.13 Million | ▲ +71.6% |
| 2019 | 0.40x | Rs43.29 Million | Rs17.48 Million | ▼ -56.7% |
| 2017 | 0.93x | Rs138.41 Million | Rs129.00 Million | ▲ +182.0% |
| 2016 | 0.33x | Rs241.74 Million | Rs79.91 Million | ▼ -98.1% |
| 2015 | 17.36x | Rs1.87 Million | Rs32.43 Million | ▲ +4103.2% |
| 2014 | 0.41x | Rs67.30 Million | Rs27.80 Million | ▼ -5.2% |
| 2013 | 0.44x | Rs57.79 Million | Rs25.17 Million | ▼ -49.8% |
| 2012 | 0.87x | Rs64.20 Million | Rs55.70 Million | ▼ -35.3% |
| 2008 | 1.34x | Rs54.94 Million | Rs73.66 Million | ▲ +3.9% |
| 2007 | 1.29x | Rs48.40 Million | Rs62.44 Million | ▼ -45.8% |
| 2006 | 2.38x | Rs24.37 Million | Rs57.99 Million | — |